XOMA Expands its Commercial Royalty and Milestone Portfolio with DSUVIA® Acquisition

 XOMA provided an $8 million non-dilutive royalty capital solution to Talphera

XOMA will receive a 15% royalty on all commercial sales and a significant portion of the 75% royalty generated by U.S. Department of Defense purchases

XOMA is entitled to no less than 50% of the potential $116.5 million in milestone payments

https://www.globenewswire.com/news-release/2024/01/18/2811533/7281/en/XOMA-Expands-its-Commercial-Royalty-and-Milestone-Portfolio-with-DSUVIA-Acquisition.html